gebhart/patrepeval huggingface dataset:
Voltage-Gated K+Channel β Subunits: Expression and Distribution of Kvβ1 and Kvβ2 in Adult Rat Brain (1996)

Recent cloning of K + channel β subunits revealed that these cytoplasmic polypeptides can dramatically alter the kinetics of current inactivation and promote efficient glycosylation and surface expression of the channel-forming α subunits. Here, we examined the expression, distribution, and association of two of these β subunits, Kvβ1 and Kvβ2, in adult rat brain. In situ hybridization using cRNA probes revealed that these β-subunit genes are heterogeneously expressed, with high densities of Kvβ1 mRNA in the striatum, CA1 subfield of the hippocampus, and cerebellar Purkinje cells, and high densities of Kvβ2 mRNA in the cerebral cortex, cerebellum, and brainstem. Immunohistochemical staining using subunit-specific monoclonal and affinity-purified polyclonal antibodies revealed that the Kvβ1 and Kvβ2 polypeptides frequently co-localize and are concentrated in neuronal perikarya, dendrites, and terminal fields, and in the juxtaparanodal region of myelinated axons. Immunoblot and reciprocal co-immunoprecipitation analyses indicated that Kvβ2 is the major β subunit present in rat brain membranes, and that most K + channel complexes containing Kvβ1 also contain Kvβ2. Taken together, these data suggest that Kvβ2 is a component of almost all K + channel complexes containing Kv1 α subunits, and that individual channels may contain two or more biochemically and functionally distinct β-subunit polypeptides.
Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells (2002)

The use of embryonic stem cells for cell-replacement therapy in diseases like diabetes mellitus requires methods to control the development of multipotent cells. We report that treatment of mouse embryonic stem cells with inhibitors of phosphoinositide 3-kinase, an essential intracellular signaling regulator, produced cells that resembled pancreatic beta cells in several ways. These cells aggregated in structures similar, but not identical, to pancreatic islets of Langerhans, produced insulin at levels far greater than previously reported, and displayed glucose-dependent insulin release in vitro. Transplantation of these cell aggregates increased circulating insulin levels, reduced weight loss, improved glycemic control, and completely rescued survival in mice with diabetes mellitus. Graft removal resulted in rapid relapse and death. Graft analysis revealed that transplanted insulin-producing cells remained differentiated, enlarged, and did not form detectable tumors. These results provide evidence that embryonic stem cells can serve as the source of insulin-producing replacement tissue in an experimental model of diabetes mellitus. Strategies for producing cells that can replace islet functions described here can be adapted for similar uses with human cells.
HUMAN PARATHYROID HORMONE CARBOXYTERMINAL PEPTIDE (53-84) STIMULATES ALKALINE PHOSPHATASE ACTIVITY IN DEXAMETHASONE-TREATED RAT OSTEOSARCOMA CELLS IN VITRO (1989)

Previous studies in our laboratory have demonstrated relatively large numbers of cell surface binding sites for the carboxylterminal (53-84) region of PTH on ROS 17/2.8 rat osteosarcoma cells, a clonal osteoblast-like cell line. In order to gain insight into the significance of these carboxylterminal binding sites, we studied the effect of intact bovine PTH (1-84), its aminoterminal fragment bovine PTH (1-34), and the human PTH carboxylterminal fragment (53-84) on alkaline phosphatase activity in dexamethasone-treated rat osteosarcoma (ROS) 17/2.8 cells. While bovine PTH (1-84) and its aminoterminal 1-34 fragment inhibited alkaline phosphatase activity, we saw a dose-related stimulation of activity by human PTH (53-84), with maximal stimulation occurring after 120 hours, at a concentration of 10(-8) M. The effect was not seen in dexamethasone-untreated cells. To our knowledge, this is the first published demonstration of biological activity of this carboxylterminal PTH peptide, previously thought to be inactive. It is likely that dexamethasone caused differentiation of cells to a type more sensitive to human PTH (53-84). Further studies are necessary to elucidate the physiological significance of these findings.
The binding of human complement component C4 to antibody-antigen aggregates (1980)

The binding of human complement component C4 to antibody-antigen aggregates and the nature of the interaction have been investigated. When antibody-antigen aggregates with optimal C1 bound are incubated with C4, the C4 is rapidly cleaved to C4b, but only a small fraction (1-2%) is bound to the aggregates, the rest remaining in the fluid phase as inactive C4b. It has been found that C4b and th antibody form a very stable complex, due probably to the formation of a covalent bond. On reduction of the C4b-immunoglobulin G (IgG) complex, the beta and gamma chains, but not the alpha' chain, of C4b are released together with all the light chain, but only about half of the heavy chain of IgG. The reduced aggregates contain two main higher-molecular-weight complexes, one shown by the use of radioactive components to contain both IgG and C4b and probably therefore the alpha' chain of C4b and the heavy chain of IgG, and the other only C4b and probably an alpha' chain dimer. The aggregates with bound C1 and C4b show maximal C3 convertase activity, in the presence of excess C2, when the alpha'-H chain component is in relatively highest amounts. When C4 is incubated with C1s in the absence of aggregates, up to 15% of a C4b dimer is formed, which on reduction gives an alpha' chain complex, probably a dimer. The apparent covalent interaction between C4b and IgG and between C4b and other C4b molecules cannot be inhibited by iodoacetamide and hence cannot be catalysed by transglutaminase (factor XIII). The reaction is, however, inhibited by cadaverine and putrescine and 14C-labelled putrescine is incorporated into C4, again by a strong, probably covalent, bond. It is suggested that a reactive group, possibly an acyl group, is generated when C4 is activated by C1 and that this reactive group can react with IgG, with another C4 molecule, or with water.
Crystal Structure of the Adenylyl Cyclase Activator G s α (1997)

The crystal structure of Gsalpha, the heterotrimeric G protein alpha subunit that stimulates adenylyl cyclase, was determined at 2.5 A in a complex with guanosine 5'-O-(3-thiotriphosphate) (GTPgammaS). Gsalpha is the prototypic member of a family of GTP-binding proteins that regulate the activities of effectors in a hormone-dependent manner. Comparison of the structure of Gsalpha.GTPgammaS with that of Gialpha.GTPgammaS suggests that their effector specificity is primarily dictated by the shape of the binding surface formed by the switch II helix and the alpha3-beta5 loop, despite the high sequence homology of these elements. In contrast, sequence divergence explains the inability of regulators of G protein signaling to stimulate the GTPase activity of Gsalpha. The betagamma binding surface of Gsalpha is largely conserved in sequence and structure to that of Gialpha, whereas differences in the surface formed by the carboxyl-terminal helix and the alpha4-beta6 loop may mediate receptor specificity.
Troglitazone reduces plasma levels of tumour necrosis factor‐α in obese patients with type 2 diabetes (2000)

We evaluated the effect of troglitazone (given orally 400 mg/day) on glucose intolerance and on the plasma levels of tumour necrosis factor-alpha (TNF-alpha) in 12 obese patients with type 2 diabetes for 12 weeks. Troglitazone significantly decreased fasting plasma glucose, serum C-peptide, serum insulin and HbA1c levels. Plasma levels of TNF-alpha were significantly reduced by troglitazone administered for 8 and 12 weeks. Troglitazone administration significantly improved insulin resistance, but did not affect pancreatic beta-cell function as evaluated by the homeostasis model assessment (HOMA). In the present study, we reported for the first time that troglitazone administration significantly reduces plasma levels of TNF-alpha in obese patients with type 2 diabetes.
Stretchable and Foldable Silicon Integrated Circuits (2008)

We have developed a simple approach to high-performance, stretchable, and foldable integrated circuits. The systems integrate inorganic electronic materials, including aligned arrays of nanoribbons of single crystalline silicon, with ultrathin plastic and elastomeric substrates. The designs combine multilayer neutral mechanical plane layouts and "wavy" structural configurations in silicon complementary logic gates, ring oscillators, and differential amplifiers. We performed three-dimensional analytical and computational modeling of the mechanics and the electronic behaviors of these integrated circuits. Collectively, the results represent routes to devices, such as personal health monitors and other biomedical devices, that require extreme mechanical deformations during installation/use and electronic properties approaching those of conventional systems built on brittle semiconductor wafers.
Molecular profiling of breast cancer (2006)

Gene-expression-based prognostic tests are now available as commercial reference laboratory tests. Their successful implementation will depend on the seamless integration with existing clinicopathologic markers.
Synthesis of New Phenanthroline‐Based Heteroditopic Ligands – Highly Efficient and Selective Fluorescence Sensors for Copper(II) Ions (2006)

Abstract The heteroditopic phenanthroline derivatives 5,6‐bis(2‐pyridylcarboxamido)‐1,10‐phenanthroline (H 2 L 1 ) and 5,6‐bis[(4‐methoxy‐2‐pyridyl)carboxamido]‐1,10‐phenanthroline (H 2 L 2 ) have been prepared and characterized, together with their luminescent ruthenium(II) complexes [Ru(bpy) 2 (H 2 L 1,2 )](PF 6 ) 2 and [Ru(H 2 L 1 ) 3 ](PF 6 ) 2 and the corresponding iron(II) complex [Fe(H 2 L 1 ) 3 ](PF 6 ) 2 . In these complexes, the metal ion is coordinated by the bidentate phen site of H 2 L. The luminescence of the ruthenium complexes ( λ ex = 450 nm, λ em ca. 620 nm) is completely quenched by Cu 2+ ions in the micromolar concentration range and, to a lesser extent, by other metal ions. At pH 5, the response of the luminescent sensors is highly Cu 2+ ‐selective. Heterodinuclear complexes [Ru(bpy) 2 (LM)](PF 6 ) 2 , [Ru(LM) 3 ](PF 6 ) 2 , and [Fe(LM) 3 ](PF 6 ) 2 have been isolated for M = Cu 2+ , Ni 2+ , Co 2+ , and Pd 2+ . It is suggested that M is coordinated to the tetradentate N4 site of L by two deprotonated amide N atoms and two pyridyl groups. This coordination type is confirmed by the EPR spectrum of the compound [Ru II (bpy) 2 (L 1 Cu II )](PF 6 ) 2 .(© Wiley‐VCH Verlag GmbH &amp; Co. KGaA, 69451 Weinheim, Germany, 2006)
From RSSI to CSI (2013)

The spatial features of emitted wireless signals are the basis of location distinction and determination for wireless indoor localization. Available in mainstream wireless signal measurements, the Received Signal Strength Indicator (RSSI) has been adopted in vast indoor localization systems. However, it suffers from dramatic performance degradation in complex situations due to multipath fading and temporal dynamics. Break-through techniques resort to finer-grained wireless channel measurement than RSSI. Different from RSSI, the PHY layer power feature, channel response, is able to discriminate multipath characteristics, and thus holds the potential for the convergence of accurate and pervasive indoor localization. Channel State Information (CSI, reflecting channel response in 802.11 a/g/n) has attracted many research efforts and some pioneer works have demonstrated submeter or even centimeter-level accuracy. In this article, we survey this new trend of channel response in localization. The differences between CSI and RSSI are highlighted with respect to network layering, time resolution, frequency resolution, stability, and accessibility. Furthermore, we investigate a large body of recent works and classify them overall into three categories according to how to use CSI. For each category, we emphasize the basic principles and address future directions of research in this new and largely open area.
Gain characteristics of a high concentration Er3+-doped phosphate glass waveguide (1995)

A channel waveguide on an erbium-doped phosphate laser glass was fabricated by a dry silver-film ion exchange technique, and its gain properties were studied experimentally. The propagation loss of the fabricated waveguide was 0.63 dB/cm at 1.3 μm. Er3+ concentration of 1×1020 ions/cm3 was chosen so that no concentration quenching occurred. This was confirmed by measuring a fluorescence lifetime of 8.4 ms at 1.54 μm. Gain of the fabricated waveguide was measured by using a Ti:sapphire laser at a wavelength of 980 nm and a laser diode of 1.532 μm producing pump and signal beams, respectively. The signal wavelength used for the experiments was shorter than the emission peak, and the measured gain of the 1.8 cm waveguide was comparable to the total loss. However, the model showed that lasing is expected at the emission peak with a 3.6 cm long waveguide fabricated in a similar manner. Calculation results showed that the potential gain of 8.8 dB can be realized with 250 mW pump power, and a 7.2 cm long waveguide provided that mode overlap can be increased by 20% and propagation loss can be reduced by 50%. No significant upconversion effect was observed up to 1.1×106 W/cm2 pump intensity.
Cloning of the gene encoding the human erythropoietin receptor (1991)

The genomic and complementary DNAs of the human erythropoietin receptor (hEpo-R) have been isolated and characterized from a genomic placental library and from two cDNA libraries prepared from bone marrow and fetal liver. The five different partial cDNAs isolated were aberrant in the predicted reading frames as compared with the Epo-R protein sequence, because all retained insert sequences that may represent splicing intermediates (three clones), cloning artifact (one clone), or a new sequence at a splice junction (one clone) of the gene. The cDNAs were used to isolate several genomic clones encompassing the complete hEpo-R gene. This gene, which encodes a 508-amino acid polypeptide chain of predicted M(r) 55,000, is organized into eight exons spread over 6 kb of DNA and exhibited a high degree of sequence homology (81.6% in the coding region) and structural organization with its murine counterpart. Primer extension analysis indicated that the transcription initiation site is located 141 bp upstream of the initiation codon. Sequence homology 320 bp upstream of the cap site was significantly lower (60%) and diverged completely further upstream as compared with the murine gene. Similarly, the human and murine sequences were largely divergent downstream of the stop codon, indicating that a strong conservation during evolution was restricted to the coding sequence of the Epo-R protein. The 320-bp region upstream of the cap site does not contain the typical TATA or CAAT boxes present in many tissue-specific genes, but does include potential binding sites for the ubiquitous Sp1 and the erythroid-specific GATA-1 trans-activating factors. These boxes are well conserved in sequence and position relative to the cap site within the promoter region of the human and murine genes, but the CACCC boxes present in the murine gene are absent in the human gene.
Conductive Fiber‐Based Ultrasensitive Textile Pressure Sensor for Wearable Electronics (2015)

A flexible and sensitive textile-based pressure sensor is developed using highly conductive fibers coated with dielectric rubber materials. The pressure sensor exhibits superior sensitivity, very fast response time, and high stability, compared with previous textile-based pressure sensors. By using a weaving method, the pressure sensor can be applied to make smart gloves and clothes that can control machines wirelessly as human-machine interfaces.
A Polycomponent Metal‐Catalyzed Aliphatic, Allylic, and Benzylic Fluorination (2012)

A group effort: Reported is the title reaction using a polycomponent catalytic system involving commercially available Selectfluor, a putative radical precursor N-hydroxyphthalimide, an anionic phase-transfer catalyst (KB(C(6)F(5))(4)), and a copper(I) bis(imine). The catalyst system formed leads to monofluorinated compounds selectively (see example) without the necessity for an excess of the alkane substrate.
A maskless post-CMOS bulk micromachining process and its application (2005)

This work investigates a post-CMOS (complementary metal-oxide semiconductor) bulk micromachining process for fabricating suspended microstructures. The advantage of the post-CMOS process is easy execution with low-cost maskless wet etching. The post-CMOS process involves wet etching to remove sacrificial layers, which are stacked layers formed from metal and via layers, to expose the silicon substrate. Then, KOH solution is employed to etch the silicon substrate to develop deep cavities and generate suspended structures. Many suspended structures, which include bridges and plates, are fabricated using the post-CMOS bulk micromachining process. With the same process, two devices that are a suspended micro inductor and a micro hot plate are manufactured successfully. Experimental results reveal that the maximum quality factor of the suspended micro inductor is 4.8 at 4 GHz, and the micro hot plate can generate a high temperature of 300 °C with an applied voltage of 4 V, which has excellent thermal isolation and heating effect.
Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin (2011)

Migrastatin is a biologically active natural product isolated from Streptomyces that has been shown to inhibit tumor cell migration. Upon completion of the first total synthesis of migrastatin, a number of structurally simplified analogs were prepared. Following extensive in vitro screening, a new generation of analogs was identified that demonstrates substantially higher levels of in vitro inhibitory activity, stability and synthetic accessibility when compared to the parent natural product. Herein, we describe two promising ether-derivative analogs, the migrastatin core ether (ME) and the carboxymethyl-ME (CME), which exhibit high efficacy in blocking tumor cell migration and metastasis in lung cancer. These compounds show an in vitro migration inhibition in the micromolar range (IC(50): ME 1.5 to 8.2 μM, CME 0.5 to 5 μM). In a human small-cell lung carcinoma (SCLC) primary xenograft model, ME and CME compounds were found to be highly potent in inhibiting overall metastasis even at the lowest dosage used (degree of inhibition: 96.2% and 99.3%, respectively). Together these very encouraging findings suggest that these analogs have promise as potent antimetastatic agents in lung cancer.
CD28 functions as an adhesion molecule and is involved in the regulation of human IgE synthesis (1995)

Activated T cells induce IgE switching in B cells via a combination of lymphokines and direct T:B cell contact. As CD28-deficient mice have reduced basal levels of IgG1 and IgG2a and diminished Ig class switching, we investigated whether the CD28/B7.1 (CD80) ligand pairing might also be involved in human IgE regulation. Co-incubation of an allergen-specific, human T cell clone with tonsillar B cells caused a marked up-regulation of CD28 expression, whereas, in contrast, CD45 RB expression was unaffected. To test whether blocking the CD28: B7.1 interaction affected IgE synthesis, a dialyzed anti-CD28 monoclonal antibody (mAb) was added to cultures containing tonsillar B cells, pre-activated T cell clones and interleukin-4. Anti-CD28 treatment caused a reproducible, dose-dependent inhibition of IgE, but not IgG synthesis that was accompanied by a visible decrease in cell aggregate formation. Conversely, an anti-B7.1 mAb had no effect in this system. The effect of blocking CD28-ligand interactions on lymphocyte adhesion was formally assessed on human T cell clones and B cell lines using dual intracellular staining and flow cytometry. Co-incubation with an anti-CD28 mAb, but not control IgG or anti-B7.1 mAb, resulted in a marked impairment of conjugate formation that correlated well with T cell surface expression of CD28. Using this system we found that an anti-CTLA-4 mAb but not an anti-B7.2 mAb inhibited T:B cell conjugate formation. Lastly, in addition to a direct effect of anti-CD28 mAb on conjugate formation, 14-day culture of T and B cells in the presence of anti-CD28 caused a marked decrease of ICAM-1 (CD54) expression on aggregated lymphocytes. In contrast, LFA-1 (CD18) expression was unaffected. We, therefore, conclude that the T cell co-stimulatory molecule CD28 is involved in the regulation of IgE synthesis in vitro. CD28 may act to a limited extent as an adhesion molecule, though apparently not by pairing with B7.1 or B7.2. It is more likely that ligation of CD28 under certain conditions modulates the expression of other T and B cell surface molecules.
Antiphospholipid Antibodies Accelerate Plasma Coagulation by Inhibiting Annexin-V Binding to Phospholipids: A “Lupus Procoagulant” Phenomenon (1998)

Abstract The antiphospholipid syndrome is a thrombophilic condition marked by antibodies that recognize anionic phospholipid-protein cofactor complexes. We recently reported that exposure to IgG fractions from antiphospholipid patients reduces the level of annexin-V, a phospholipid-binding anticoagulant protein, on cultured trophoblasts and endothelial cells and accelerates coagulation of plasma exposed to these cells. Therefore, we asked whether antiphospholipid antibodies might directly reduce annexin-V binding to noncellular phospholipid substrates. Using ellipsometry, we found that antiphospholipid IgGs reduce the quantity of annexin-V bound to phospholipid bilayers; this reduction is dependent on the presence of β2-glycoprotein I. Also, exposure to plasmas containing antiphospholipid antibodies reduces annexin-V binding to phosphatidyl serine-coated microtiter plates, frozen thawed washed platelets, activated partial thromboplastin time (aPTT) reagent and prothrombin time reagent and reduces the anticoagulant effect of the protein. These studies show that antiphospholipid antibodies interfere with the binding of annexin-V to anionic phospholipid and with its anticoagulant activity. This acceleration of coagulation, due to reduced binding of annexin V, stands in marked contrast to the “lupus anticoagulant effect” previously described in these patients. These results are the first direct demonstration of the displacement of annexin-V and the consequent acceleration of coagulation on noncellular phospholipid surfaces by antiphospholipid antibodies. © 1998 by The American Society of Hematology.
A critical review of the techniques for testing insecticides (1971)

A critical review of the techniques for testing insecticides , A critical review of the techniques for testing insecticides , مرکز فناوری اطلاعات و اطلاع رسانی کشاورزی
Antimonides with the half-Heusler structure: New thermoelectric materials (1999)

The thermoelectric properties near ambient temperature of half-Heusler alloys based on LnPdSb, where Ln=Ho, Er, and Dy are reported. The Seebeck coefficients are large, between 60 and 250 μV/K, and the materials are p type. The resistivities are between 0.6 and 20 mΩ cm. Thermal conductivities are between approximately 5.0 and 3.5 W/mK at 300 K, and are smallest in intentionally disordered materials. The highest ambient temperature ZT obtained is 0.06. Band-structure calculations are presented for LuPdSb. It is suggested that half-Heusler alloys with 18 electrons per formula unit may represent a large class of thermoelectric materials.
Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects (1992)

Cigarette smokers receive significantly higher neuroleptic doses, in part because of a smoking-induced increase in neuroleptic metabolism. Smoking is also associated with significant reduction in levels of parkinsonism. Smoking status is a significant factor that should be considered in assessment of neuroleptic dose requirements and neuroleptic side effects.